Molecular Resilience, Inc and other shareholders entered into a letter of intent to sell Fortitude Group, Inc. (OTCPK:FRTD) for $3 million in stock on May 18, 2014. The buyer will exchange each share of Fortitude with its share at consideration of $0.12 per share. The letter of intent includes a 10 day due diligence period with an estimated closing date for the transaction of May 30, 2014.

Molecular Resilience, Inc and other shareholders cancelled the sale of Fortitude Group, Inc. (OTCPK:FRTD) recently.